Mario Gargiulo is SVP, Ops, Biologics Europe of Catalent, Inc.. Currently has a direct ownership of 5,676 shares of CTLT, which is worth approximately $360,312. The most recent transaction as insider was on May 01, 2023, when has been sold 678 shares (Common Stock) at a price of $49.86 per share, resulting in proceeds of $33,805. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.68K
0% 3M change
0% 12M change
Total Value Held $360,312

Mario Gargiulo Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 01 2023
SELL
Open market or private sale
$33,805 $49.86 p/Share
678 Reduced 10.67%
5,676 Common Stock
Aug 25 2022
SELL
Open market or private sale
$163,421 $103.04 p/Share
1,586 Reduced 19.97%
6,354 Common Stock
Aug 24 2022
BUY
Grant, award, or other acquisition
-
3,432 Added 30.18%
7,940 Common Stock
Jul 26 2022
SELL
Open market or private sale
$103,586 $106.9 p/Share
969 Reduced 20.88%
3,671 Common Stock
Jul 26 2022
BUY
Grant, award, or other acquisition
-
837 Added 15.66%
4,508 Common Stock
Jun 10 2022
SELL
Open market or private sale
$12,578 $106.59 p/Share
118 Reduced 2.48%
4,640 Common Stock
MG

Mario Gargiulo

SVP, Ops, Biologics Europe
Somerset, NJ

Track Institutional and Insider Activities on CTLT

Follow Catalent, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTLT shares.

Notify only if

Insider Trading

Get notified when an Catalent, Inc. insider buys or sells CTLT shares.

Notify only if

News

Receive news related to Catalent, Inc.

Track Activities on CTLT